ADIM
PRLB icon

Alpha DNA Investment Management’s Protolabs PRLB Stock Holding History

Alpha DNA Investment Management’s Portfolio PRLB Stock Details PRLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24
Closed -$2K – 508
2021
Q1 		$2K Buy
+24
New +$3.99K ﹤0.01% 578

Other funds holding PRLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Alpha DNA Investment Management's PRLB Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Protolabs (PRLB) in Q2 2021, closing a stake of 24 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in PRLB in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 273 funds tracked by Wall St. Rank hold PRLB as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Protolabs position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 24 Protolabs shares in Q2 2021, an estimated $2K.
  • Alpha DNA Investment Management first reported a position in Protolabs in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Protolabs position peaked at $2K in Q1 2021.
  • 273 funds tracked by Wall St. Rank held Protolabs as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.